Treatment strategy, stroke severity, and functional outcomes in acute ischemic stroke: evidence of effect modification in a real-world cohort.

Authors

Karlygash Shinalieva, Arystan Zhakupbekov, Aigul Kaisarbekova, Murat Talasbayev, Aliya Omarbek, Adelya Beisenbekova, Aigerima Turebekova

Published in

Neurological research. Pages 1-13. Sep 11, 2026. Epub Sep 11, 2026.

Abstract

To explore the association between treatment strategy and functional outcomes in acute ischemic stroke (AIS) and assess whether this association is modified by stroke severity and imaging findings.
We conducted a retrospective single-center cohort study of adults with AIS treated between March 2023 and September 2025 at a tertiary stroke center in Central Asia. Patients were categorized into intravenous thrombolysis, selective intra-arterial thrombolysis, or angiography without thrombolysis. The primary outcome was poor functional outcome, defined as modified Rankin Scale (mRS) score ≥ 3 at discharge. Multivariable logistic regression and interaction analyses were performed.
A total of 247 patients were included, of whom 60.3% had poor functional outcomes. Outcomes differed significantly between treatment groups (p = 0.024), with favorable outcomes more common after intravenous thrombolysis than after selective intra-arterial thrombolysis or angiography without thrombolysis. In multivariable analysis, both selective intra-arterial thrombolysis (OR 2.23, 95% CI 1.04-4.78) and angiography without thrombolysis (OR 2.70, 95% CI 1.23-5.92) were associated with higher odds of poor outcome than intravenous thrombolysis. A significant interaction was observed between treatment strategy and admission NIHSS (Pinteraction < 0.001), whereas the interaction with MRI-confirmed ischemia was not significant (Pinteraction = 0.066). Admission NIHSS demonstrated modest predictive performance (AUC 0.65, 95% CI 0.56-0.74).
In this exploratory observational cohort, treatment strategy was associated with functional outcome at discharge, and this association varied according to baseline stroke severity. Because treatment allocation was non-random and residual confounding cannot be excluded, these findings should be considered hypothesis-generating rather than causal evidence of treatment effectiveness.

PMID:
42723440
Bibliographic data and abstract were imported from PubMed on 11 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.